ArchiveSCV
the-signal.com. The Santa Clarita Valley Signal. Back to the collection.

· the-signal.com, Wayback capture

Tough Bugs

Ever since 1928, when Scottish scientist Alexander Fleming discovered the first antibiotic, we have had a growing sense of microbial security— a belief that we are protected from all harmful bacteriological infections.

As legion antibiotics have flooded the market, promising and delivering knock-out punches for the bugs that ail us, another interesting phenomenon—“antibiotic resistance” — has occurred. Such resistance allows some bacteria to become “superbugs,” bacteria that survive, multiply and become impervious to the anti-microbial drugs that once sent them packing.

Over-usage of Antibiotics

Widespread use of antibiotics has helped to promote such resistance, reports the Centers for Disease Control and Prevention (CDC). They estimate that about 100 million courses of antibiotics are provided by office-based doctors each year— that’s about 235 million doses consumed annually. And according to the CDC, half of those are unnecessary— being prescribed for colds, coughs and other viral infections.

While antibiotics are highly effective in killing bacteria that cause maladies like strep throat, and skin and ear infections, they are useless when given for non-bacterial infections. In fact, their presence in the body when not taken for bacterial infections, increases one’s chances for developing antibiotic-resistant infections.

Vicki Norris, R.N., Infection Control Nurse at Henry Mayo Newhall Memorial Hospital is a medical professional who carefully reviews infections at the community hospital and identifies any occurring trends.

As an Infection Control nurse it is her job to track infections that come into the facility as well as those that develop as a result of being hospitalized ( hospital-acquired infections are known as “nosocomial infections”). Antibiotic-resistant infections are among those watched for.

Information gathered through ongoing hospital surveillance goes directly to the Infection Control Committee where it is reviewed for any actions for improvement. This committee, Norris explained, is comprised of an Infectious Disease doctor and representatives from each department of the hospital as well as other physicians.

Norris concurs that bacteria can mutate during the use of antibiotics, and become resistant to those same drugs.

“This can be particularly dangerous to the very sick, the elderly and the very young,” Norris said. “They are more susceptible because their immune systems cannot fight off the bacteria as readily.”

Antibiotic-Resistant Infections

An antibiotic-resistant infection is an infection that is difficult or impossible to cure with antibiotics. Ear, sinus, throat, lungs and intestines are common sites for these infections. Not only can they be extremely hard to treat, they often result in longer and more severe illnesses, some necessitating hospitalization.

When treating antibiotic-resistant infections doctors often use higher doses of antibiotics, or may administer the medication in a different way, such as intravenously.

There are three ways that one can “catch“ an antibiotic-resistant infection. They are:

• From taking antibiotics— Bacteria that has been repeatedly exposed to antibiotics develop ways to fight them and survive. When they start to multiply, they can cause serious symptoms.

l When the bacteria inside of your body exchange, share or copy genes that allow them to resist antibiotic treatment.

• From persons or inanimate objects (known as “fomites”) around you that are infected with resistant bacteria. Resistant bacteria is frequently found among people in hospitals, nursing homes or day-care centers. Improper hand-washing can promote the spread of such infections.

Norris, a long-time HMNMH nurse who has worked in the Infection Control department for three years, said that as bacteria can be spread by direct contact with the hands of a healthcare workers or by patients who are infected or carry the organism, careful handwashing is a must.

“Handwashing is the most effective way to control the spread of any organism, including resistant organisms— in every environment,” she noted.

Within the healthcare setting and in the home, handwashing is indeed, our greatest tool in the war against germs. As the skin is the body’s first line of defense against invading microbes, scrupulous handwashing can help break the chain of infection. (Except in healthcare settings, there is no evidence that the use of antibacterial products prevent infections any better than ordinary soap. Hand washing with ordinary soap and water, using sufficient friction, is highly effective in reducing the risk of the most common infections and does not add to antibiotic resistance.)

Threat to Public Health

Antibiotic resistance is a major contributor to the disease, death and costs resulting from hospital-acquired infections. Although there are presently no hard numbers illustrating the dollar amounts, one report placed an annual cost of antimicrobial resistance among a single pathogen (staph aureus— a bacteria normally found on the skin of healthy people) at $122 million!

The CDC reports that each year, nearly 2 million patients in the United States get an infection as a result of receiving health care in a hospital. These hospital-acquired infections can be especially hard to treat when the bacteria (the most common culprits) and other microorganisms (this includes fungi and viruses) that cause them are resistant to antimicrobial drugs.

Additionally, in what seems like a masterminded microbiological plot, once a particular type of bacteria has developed drug-resistance , it can pass on that resistance to other types of bacteria.

Overall, 70 percent of the bacteria causing such infections are resistant to at least one of the drugs most commonly used to treat them. In some cases, these microbes are resistant to all approved antibiotics and must be treated with experimental, potentially toxic drugs.

The more often an antibiotic is used, warns the CDC, the more likely bacteria are to develop resistance to it. Therefore, to combat the problem of drug-resistant bacteria, the CDC has developed certain recommendations which, together with other CDC guidelines for infection control, are helping to limit the spread of drug-resistant infections in our nation’s hospitals.

The CDC and other healthcare organizations, such as the Society for Healthcare Epidemiology of America, the Association for Professionals in Infection Control and Epidemiology, the Infectious Diseases Society of America, and the American Academy of Pediatrics are all working to improve antimicrobial prescription practices. As an example of these efforts, the CDC recently sponsored a national videoconference for healthcare workers to improve the use of vancomycin (a first-line drug used to combat serious staphylococcal and enterococcal infections). Another videoconference on antimicrobial use will be held later this year.

A Pest of Pestilence: MRSA

These days, methicillin-resistant staphylococcus aureus (MRSA) is a real buzz word in the medical world. In a nutshell, here’s what it’s all about: Although staph is normally found on the skin, occasionally it can get into the body and cause infection. These can be minor (i.e., pimples, boils or other skin conditions) or major (more serious infections like pneumonia).

Methicillin is an antibiotic commonly and successfully used to treat staph infections, however, some staph germs have developed resistance to the drug along the way. These bacteria are referred to as methicillin-resistant staph-aureus , or MRSA. It is possible to become colonized with MRSA. This means that MRSA is present in the body without causing illness.

An MRSA infection indicates that the microbes are making the person ill. MRSA infections usually develop in hospital patients who are elderly, very sick, have an open wound (such as a bedsore from prolongued bed rest and skin pressure), or a tube (such as a urinary catheter) going into their body. MRSA can be found on the skin, in the nose, and in the blood and urine. Healthy people rarely get MRSA.

According to some estimates, as many as 80,000 patients get an MRSA infection after entering the hospital. At this time, the number of those colonized with the bug is unknown.

Although MRSA is resistant to many antibiotics and often quite difficult to treat, a few antibiotics can still successfully cure MRSA infections. The CDC reports that patients who are colonized with MRSA do not necessarily need treatment.

Norris emphasized that while resistant bacteria (such as MRSA) can be spread from one person to the next, those with compromised immune systems are the most vulnerable. (As stated before, the very sick, the elderly and the very young.)

MRSA is almost always spread through physical contact and not through the air. Hospitals take special precautions to prevent such spread by isolating their MRSA patients and making sure that hospital staff follow strict isolation guidelines when caring for them.

Isolation Procedures

Per CDC reports, isolation procedures may vary from one institution to another, but the following often occurs:

• The patient is placed in a private room, or in a room with one or more patients who also have MRSA.

• The patient’s movement from room to room is limited to essential purposes only, such as for medical procedures or emergencies.

• Health care workers usually wear gloves (and sometimes hospital gowns and masks) before entering patient’s rooms, and remove the gloves (gowns and masks) before leaving the room. Then they immediately wash their hands.

• Visitors may also be asked to put on such medical protection, especially if they are likely to come in contact with the patient’s blood, skin, urine, wound or other body substances. Visitors should always wash their hands before leaving the patient’s room. This helps to make sure that MRSA does not leave the room with them.

The length of MRSA isolation is variable. Hospital staff will determine when it is safe for the MRSA patient to come off of isolation. This is generally based on laboratory tests and patient symptoms. Because MRSA is difficult to treat, isolation may last days, weeks or longer.

Patients who go home with MRSA pose special concerns to those caring for them. Besides frequent handwashing, the CDC recommends periodic cleaning of the patient’s room and personal items with a commercial disinfectant or a fresh solution of one-part bleach and 100 parts water (for example, one tablespoon bleach in one quart of water). It is also recommended that gloves are worn if body substances are handled (i.e., blood, urine, wound drainage), and that hands are carefully washed following such procedures.

MRSA should pose no threat to healthy persons caring for them or living around them so long as proper precautions are followed. However, persons who are very ill or those with weak immune systems should avoid handling the body substances of persons with MRSA and should limit their contact with them.

New Drugs, New Hopes

As previously reported last month in MedBytes, the FDA has recently approved a vital new weapon in the battle against drug-resistant bacteria. That drug, Zyvox, is described as the first entirely new type of antibiotic in 35 years. Used to treat routine pneumonia, skin infections and some drug-resistant staphylococcus infections, its chief fight will be against an infamous germ, called Enterococcus faecium— which often invades surgery wounds, as well as causing deadly infections in the abdomen, urinary tract, and heart valves. Enterococcus faecium is unscathed by the current antibiotic of last resort, Vancomycin.

As more and more germs develop resistance to Vancomycin (long referred to as a “silver bullet” drug), doctors have watched helplessly as their patients die from once-treatable infections. Those same doctors now have high hopes for Zyvox. In clinical trials of 145 patients with Vancomycin-resistant Enterococcus infections, the drug cured 67%, the Food and Drug Administration reports. But Zyvox isn’t alone in the battle against resistant bacteria. Last fall the FDA approved competitor Aventis’ Synercid as the nation’s first alternative when Vancomycin fails.

Experts say both new drugs are important weapons that should be used sparingly and only against the worst infections, because bacteria eventually will evolve to evade them, too. While Synercid is a combination of two older and little-used types of antibiotics, Zyvox is a brand-new chemical compound that fights germs at an entirely different point in their life cycle. Known chemically as linezolid, it is the first in a long-awaited new class of antibiotics called oxazolidinones.

It’s not a magic bullet, researchers caution, and it can’t fight all bacteria— only those known as “ gram-positive ” germs. Still, gram-positive bacteria cause more than half of all serious infections treated in hospitals worldwide, the kind often caught by patients while they’re in the hospital for some other problem. In clinical trials using Zyvox against other infections (including hard-to-treat staph infections), Zyvox proved as effective as Vancomycin.

Wise Antibiotic Use

Antibiotics must be prescribed and used judiciously. Although the CDC and other healthcare organizations have developed guidelines for the use of antibiotics in hospitals, some research indicates that antibiotics are being given far more than recommended.( A recent study indicated that as much as 60 percent of the hospital prescriptions for one of these drugs, vancomycin, are not in accordance with these guidelines.)

Patients can, and should, serve as their own antibiotic advocates.

By NOT hounding their physicians to prescribe antibiotics for such transient maladies as colds (and other viral infections), they stand a better chance of not developing antibiotic resistance.

Quite often, the CDC rep orts, some doctors “give in” to their patient’s requests, finding it easier to just write out a prescription than try and make the patient understand why grasping for antibiotics may be a poor move.

Not taking antibiotics as prescribed is also a bad choice. Stopping the medication before the course is completed— “because I feel so much better now” — is what many people do. What this practice may succeed in is not killing the infecting organism entirely, thus allowing the most resistant ones to multiply in the body.

Saving antibiotics and then “ self-prescribing ” is also another mistake, as is “lending out” unused antibiotics to relatives and friends.

Vicki Norris urges everyone to exercise good judgement when using antibiotics.

“Careful use of existing antibiotics and restricting the use of new antibiotics may be our only hope against these superbugs,” she said.

← Back to 2000

About this record

How it was held, read and classified

Record details

Morris ID
Not a Morris ID. This record is keyed ts-df:/editorial/sevanian/0500/051800b.html.
System
date-file pages (/desk/MMYY/MMDDYY.html)
Reading copy
the-signal.com
Chosen by: only copy held. On this copy: words 2,279 (e-mail addresses counted as one token); reader comments 0 (counted, not reproduced here); images 0.
Extracted by
datefile:START_STORY
signal-extract/0.15 (2026-11-16)

Other copies

Held
None. The holding has this article from one host only.

How it was classified

Label
clearly-local
Judgment
A machine’s (recorded as machine), kept as one so it can be revisited.
Classifier
signal-localclass/0.7 (2026-11-12)
Local signals
  • url:datefile_editorial
  • text:valley_names [2 distinct/2 mentions: Newhall, Henry Mayo]
  • byline:named_writer_no_wire_credit [by Diana Sevanian, R.N.]
National signals
none fired
Scores
local 7, national 0